Tetragon Partners GP Ltd 13F: Portfolio & Holdings
In its most recent SEC Form 13F-HR filing (as of Q1 2026), Tetragon Partners GP Ltd (SEC CIK 0001515070) reported 34 equity positions with a combined market value of $0.5 billion, plus $6.2 million of listed call option notional. The Grand Cayman-based hedge fund maintains a highly concentrated portfolio with a Technology sector tilt, which represents 63.4% of its exposure.
Its largest holdings are Uipath INC (PATH) at 55.0%, Kolibri Global Energy INC (KGEI) at 7.4%, and Warner Bros Discovery INC (WBD) at 5.0%.
The largest new position was Warner Bros Discovery INC (WBD) at 5.0% of the portfolio. See the fund’s full Q1 2026 buys, sells, and portfolio changes →
Based on published SEC 13F filings, Tetragon Financial Group's closest peer funds by portfolio overlap are Commodore Capital LP (35.1%), Exome Asset Management LLC (22.3%), and Deep Track Capital, LP (20.6%).
- 13F AUM
- $0.5B
- Equity Positions
- 34
- Top-10 Concentration
- 83.0%
- Largest Sector · 63.4%
- Technology
- Longest-Held Position · 32 qtrs
- AUTL
- Median Holding Period
- 3 Qtrs
What are Tetragon Financial Group’s largest 13F holdings as of Q1 2026?
Largest 13F positions disclosed by Tetragon Financial Group, ranked by portfolio weight. Full multi-quarter history and the broader institutional holder base for each ticker linked per row.
| # | Issuer | Ticker | Sector | Weight | Position Value | Detail |
|---|---|---|---|---|---|---|
| 1 | UIPATH INC | PATH | Technology | 55.0% | $279.8M | Position History All Holders |
| 2 | KOLIBRI GLOBAL ENERGY INC | KGEI | Energy | 7.4% | $37.5M | Position History All Holders |
| 3 | WARNER BROS DISCOVERY INC NEW | WBD | Communication Services | 5.0% | $25.4M | Position History All Holders |
| 4 | WORKIVA INC | WK | Technology | 2.9% | $14.9M | Position History All Holders |
| 5 | LYFT INC | LYFT | Technology | 2.6% | $13.3M | Position History All Holders |
| 6 | SPRINKLR INC | CXM | Technology | 2.6% | $13.2M | Position History All Holders |
| 7 | AUTOLUS THERAPEUTICS LTD | AUTL | Healthcare | 2.6% | $13.1M | Position History All Holders |
| 8 | CELLDEX THERAPEUTICS INC | CLDX | Healthcare | 1.9% | $9.9M | Position History All Holders |
| 9 | ARROWHEAD PHARMACEUTICALS INC | ARWR | Healthcare | 1.6% | $8.0M | Position History All Holders |
| 10 | NEKTAR THERAPEUTICS | NKTR | Healthcare | 1.5% | $7.4M | Position History All Holders |
View Tetragon Financial Group's Q1 2026 portfolio changes and trading report →
Portfolio composition
Sectors, concentrations, and a tap-through treemap of every position in the fund's latest 13F.
Holding period analytics
Distribution of holding periods for all 597 stocks the fund has ever held (up to selected quarter):
Which Funds Hold a Similar Portfolio to Tetragon Financial Group?
Ranked by percentage of the peer fund's 13F equity portfolio that overlaps with Tetragon Financial Group's positions in Q1 2026.
| # | Fund | Shared Positions | Overlap % |
|---|---|---|---|
| 1 | Commodore Capital LP | 8 | 35.1% |
| 2 | Exome Asset Management LLC | 7 | 22.3% |
| 3 | Deep Track Capital, LP | 9 | 20.6% |
| 4 | Saturn V Capital Management LP | 3 | 20.3% |
| 5 | Avoro Capital Advisors LLC | 5 | 16.1% |
| 6 | Optimus Prime Fund Management Co., Ltd. | 3 | 15.5% |
| 7 | Lynx1 Capital Management LP | 1 | 14.0% |
| 8 | Baker Bros. Advisors LP | 12 | 13.6% |
| 9 | Tweedy, Browne Co LLC | 1 | 13.6% |
| 10 | Frazier Life Sciences Management, L.P. | 7 | 12.5% |
How Has Tetragon Financial Group's AUM Changed Over Time?
Quarterly 13F-reported AUM for Tetragon Financial Group, derived from aggregate reported position market values disclosed to the U.S. SEC.
| Quarter | 13F AUM (USD) | QoQ Change |
|---|---|---|
| Q1 2016 | $303M | — |
| Q2 2016 | $387M | +0.1B |
| Q3 2016 | $512M | +0.1B |
| Q4 2016 | $493M | -0.0B |
| Q1 2017 | $521M | +0.0B |
| Q2 2017 | $660M | +0.1B |
| Q3 2017 | $615M | -0.0B |
| Q4 2017 | $612M | -0.0B |
| Q1 2018 | $643M | +0.0B |
| Q2 2018 | $743M | +0.1B |
| Q3 2018 | $836M | +0.1B |
| Q4 2018 | $618M | -0.2B |
| Q1 2019 | $804M | +0.2B |
| Q2 2019 | $689M | -0.1B |
| Q3 2019 | $561M | -0.1B |
| Q4 2019 | $673M | +0.1B |
| Q1 2020 | $577M | -0.1B |
| Q2 2020 | $750M | +0.2B |
| Q3 2020 | $985M | +0.2B |
| Q4 2020 | $1.5B | +0.5B |
| Q1 2021 | $1.4B | -0.1B |
| Q2 2021 | $1.8B | +0.4B |
| Q3 2021 | $1.6B | -0.2B |
| Q4 2021 | $1.6B | +0.0B |
| Q1 2022 | $2.2B | +0.6B |
| Q2 2022 | $1.4B | -0.8B |
| Q3 2022 | $830M | -0.6B |
| Q4 2022 | $697M | -0.1B |
| Q1 2023 | $747M | +0.1B |
| Q2 2023 | $741M | -0.0B |
| Q3 2023 | $548M | -0.2B |
| Q4 2023 | $394M | -0.2B |
| Q1 2024 | $364M | -0.0B |
| Q2 2024 | $323M | -0.0B |
| Q3 2024 | $314M | -0.0B |
| Q4 2024 | $324M | +0.0B |
| Q1 2025 | $312M | -0.0B |
| Q2 2025 | $554M | +0.2B |
| Q3 2025 | $689M | +0.1B |
| Q4 2025 | $474M | -0.2B |
| Q1 2026 | $509M | +0.0B |
Methodology & FAQ
How We Track Tetragon Financial Group Holdings
Our data is systematically aggregated directly from quarterly Form 13F-HR disclosures submitted to the U.S. Securities and Exchange Commission (SEC).
- Who Must File (Reporting Threshold): This dataset includes filings from U.S. institutional investment managers, hedge funds, mutual funds, university endowments, and family offices managing at least $100 million in Section 13(f) securities (including equities, options, convertibles, ETFs, and warrants).
- What is Included (Data Scope): By regulation, 13F filings include long positions in U.S. exchange-listed stocks, ETFs, shares of closed-end investment companies, and convertible debt, as defined in the SEC's official Section 13(f) securities list . For listed options (calls/puts) the reported value is based on the notional value.
- Portfolio Weight Explained (Metric Definition): “Portfolio Weight” shows how much of a fund's total reported 13F portfolio value (excluding listed options) is allocated to a specific position on the reporting date.
- How to Use This Data (Interpretation): Quarter-over-quarter changes in shares and portfolio weight reflect a combination of active trading and market price movements. These are descriptive metrics of fund allocation, not explicit buy or sell signals.
What does Tetragon Financial Group's 13F filing disclose about their portfolio?
A Form 13F-HR filed by Tetragon Financial Group with the U.S. SEC discloses all long positions in Section 13(f) securities — U.S.-listed equities, ETFs, closed-end funds, and listed put/call options — held at quarter-end with a market value of at least $200,000 or 10,000 or more shares. Pactolio aggregates these filings to surface the manager’s reported portfolio weights, share counts, and quarter-over-quarter portfolio changes in a structured format. The filing represents a point-in-time snapshot of disclosed long-side exposure, not a real-time or complete view of the fund’s total book.
How do you measure conviction in Tetragon Financial Group's portfolio allocations?
Conviction is measured by portfolio weight — the percentage of Tetragon Financial Group’s total reported 13F market value allocated to a given position — rather than by absolute share count or dollar value alone. A position representing a disproportionately large share of the fund’s disclosed book signals high-conviction allocation, regardless of whether it ranks among the fund’s largest absolute holdings.
What is excluded from Tetragon Financial Group's 13F — short positions, swaps, and derivatives?
SEC Form 13F requires disclosure of long positions only. Specifically excluded are: short interest, total return swaps, credit default swaps, and all OTC derivatives — none of which appear in 13F filings regardless of position size. Listed put and call options must be disclosed but are excluded from portfolio weight calculations on this platform so that reported weights reflect direct equity exposure and remain comparable across filers. This means Tetragon Financial Group’s 13F represents the reported long book, which may differ materially from its net economic exposure.
When is Tetragon Financial Group's 13F data available, and how large is the reporting lag?
Investment managers must submit Form 13F within 45 calendar days of each quarter-end (the T+45 deadline). Pactolio ingests filings directly from SEC EDGAR as they are published — managers who file early appear in our system before the deadline, while late filers are captured on their actual filing date. The quarter label shown at the top of this page reflects the most recently processed 13F cycle for Tetragon Financial Group. The inherent reporting lag means the data always reflects positions as of the prior quarter-end, not current holdings.
Who must file a Form 13F with the SEC, and does Tetragon Financial Group qualify?
Under SEC Rule 13f-1, any investment manager — including hedge funds, family offices, registered investment advisers, pension funds, and university endowments — that exercises investment discretion over $100 million or more in Section 13(f) securities at any point during a calendar year must file Form 13F for that year. Tetragon Financial Group meets this threshold, which is why its holdings are publicly disclosed and accessible on this platform. The $100 million threshold is evaluated on a rolling basis, meaning new filers can enter and existing filers can exit the disclosure regime as AUM crosses that boundary.